Quarterly report pursuant to sections 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Notes to Financial Statements
1. Organization and basis of presentation
2. Summary of significant accounting policies
3. Certain relationships and related transactions
4. Convertible Debentures
5. Capital stock
6. Stock Options and warrants
7. Research and development
8. Derivative liability
9. Commitments and contingencies
10. Other income
11. Subsequent events
Accounting Policies
1. Organization and basis of presentation (Policies)
2. Summary of significant accounting policies (Policies)
Notes Tables
2. Summary of significant accounting policies (Tables)
4. Convertible Debentures (Tables)
6. Stock Options and warrants (Tables)
8. Derivative liability (Tables)
Notes Details
1. Organization and basis of presentation (Details Narrative)
2. Summary of significant accounting policies (Details)
2. Summary of significant accounting (Details Narrative)
3. Certain relationships and related (Details Narrative)
4. Convertible Debentures (Details)
4. Convertible Debentures (Details Narrative)
5. Capital stock (Details Narrative)
6. Stock Options and warrants (Details)
6. Stock Options and warrants (Details 1)
6. Stock Options and warrants (Details Narrative)
7. Research and development (Details Narrative)
8. Derivative liability (Details)
9. Commitments and contingencies (Details Narrative)
10. Other income (Details Narrative)
11. Subsequent events (Details Narrative)
7. Research and development (Details Narrative)
v2.3.0.11
7. Research and development (Details Narrative) (USD $)
3 Months Ended
6 Months Ended
174 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expenses
$ 183,424
$ 81,213
$ 350,890
$ 552,568
$ 7,795,887
Temple University Research Development Agreement [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expenses
93,750
License maintenance fee paid
100,000
Annual maintenance fees
187,500
Royalty fee, Minimum rate
0.04
Royalty fee, Maximum rate
0.07
Revenues generated from sub-licensees
0.25
Temple's patent rights licensed to the Company
Temple also agreed to defer payment of the $37,500 of the amount due if the Company agrees to fund at least $250,000 in research or development of Temple's patent rights licensed to the Company.
Sponsored Research Agreement [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expenses
62,500
AOT Testing [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Costs incurred for the testing
$ 182,692
X
- Details
Name:
us-gaap_LicenseCosts
Namespace Prefix:
us-gaap
Data Type:
xbrli:monetaryItemType
Balance Type:
debit
Period Type:
duration
X
- Details
Name:
us-gaap_MaintenanceCosts
Namespace Prefix:
us-gaap
Data Type:
xbrli:monetaryItemType
Balance Type:
debit
Period Type:
duration
X
- Details
Name:
us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:
us-gaap
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:
us-gaap
Data Type:
xbrli:monetaryItemType
Balance Type:
debit
Period Type:
duration
X
- Definition
Custom Element.
+ Details
Name:
zero_CostsIncurredForTesting
Namespace Prefix:
zero
Data Type:
xbrli:monetaryItemType
Balance Type:
debit
Period Type:
duration
X
- Definition
Custom Element.
+ Details
Name:
zero_RevenuesGeneratedFromSublicensees
Namespace Prefix:
zero
Data Type:
xbrli:monetaryItemType
Balance Type:
credit
Period Type:
duration
X
- Definition
Custom Element.
+ Details
Name:
zero_RoyaltyFeeMaximumRate
Namespace Prefix:
zero
Data Type:
xbrli:pureItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Custom Element.
+ Details
Name:
zero_RoyaltyFeeMinimumRate
Namespace Prefix:
zero
Data Type:
xbrli:pureItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Custom Element.
+ Details
Name:
zero_TemplesPatentRightsLicensedToCompany
Namespace Prefix:
zero
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration